Berberine Research Overview (also known as Berberine HCl, Berberine Hydrochloride, Dihydroberberine, DHB, Natural Metformin)

At a glance

Berberine research overview

What Is Berberine?

Berberine is an isoquinoline alkaloid found naturally in several plants including Berberis vulgaris (barberry), Berberis aristata (tree turmeric), Coptis chinensis (goldenseal), and Phellodendron amurense. It has been used in traditional Chinese and Ayurvedic medicine for thousands of years, primarily for its antimicrobial and gastrointestinal effects. Modern research has repositioned berberine as one of the most pharmacologically compelling plant-derived compounds available, particularly for metabolic health — with clinical data suggesting effects comparable to the pharmaceutical drug Metformin for blood glucose management.

Berberine's rise in the longevity and biohacking community stems from its multi-pathway activity: it activates AMPK (AMP-activated protein kinase), modulates the gut microbiome, improves insulin sensitivity, reduces LDL cholesterol, and activates several longevity-associated signaling pathways. Its oral bioavailability is limited (approximately 5%) due to extensive first-pass metabolism, which has led to the development of dihydroberberine (DHB) — a reduced, more bioavailable form that converts back to berberine in the intestinal wall and achieves roughly 5x higher plasma concentrations at equivalent doses.

Quick Reference

Member reference tables summarize the compound's research parameters.

Sign in to view this section

Research Indications

Glycemic Control
Strong Evidence

Type 2 diabetes adjunct research

Randomized clinical studies have reported reductions in fasting glucose, postprandial glucose, and HbA1c in people with type 2 diabetes, though it should not replace prescribed care.

Insulin sensitivity pathways

Preclinical and mechanistic work implicates AMPK activation, altered hepatic gluconeogenesis, and increased glycolytic activity.

Lipid Metabolism
Supported Research

LDL cholesterol reduction

Human studies support modest improvements in LDL cholesterol and triglycerides; proposed mechanisms include increased hepatic LDL-receptor expression.

Mixed dyslipidemia

Meta-analyses suggest benefit across several lipid markers, but study formulations, durations, and background treatments vary substantially.

Gut Microbiota & Healthy Aging
Emerging Evidence

Microbiome modulation

Berberine has low oral bioavailability and may exert part of its metabolic activity through changes in intestinal microbial composition and microbial metabolism.

Longevity-relevant signaling

AMPK- and mitochondrial-related findings are largely mechanistic or preclinical; direct evidence that berberine extends healthy human lifespan is not established.

Research Protocols

As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.

This member section describes parameters reported in the research literature.

Sign in to view this section

Peptide Interactions

This member section summarizes reported compound interactions and evidence limitations.

Sign in to view this section

Reported Research Time Points

This member section summarizes reported research time points.

Sign in to view this section

Safety Notes

Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.

This member section discusses research safety considerations and uncertainties.

Sign in to view this section

Quality Indicators

Verified Marker

Batch-specific certificate of analysis

The described verification process includes looking for a lot-number-matched COA reporting identity and assay results for the finished or clearly identified raw material.

Verified Marker

Independent purity testing

Prefer third-party HPLC or comparable chromatographic testing that identifies berberine content and reports a quantitative purity result.

Verified Marker

Contaminant panel disclosure

A quality product provides recent results for heavy metals and microbiological contaminants, with methods or laboratory information available.

Acceptable Range

Clear capsule dosage and form

The label should state milligrams of berberine per capsule and identify the salt or extract form; the listed text specifies avoiding relying on proprietary blends for dose accuracy.

Quality Concern

Missing COA or implausible potency claims

The listed research text specifies avoiding products that provide no batch documentation, conceal ingredient amounts, or make drug-like claims without substantiating test data.

Research Citations

Research Focus

AMPK activation, insulin sensitivity, blood glucose, LDL cholesterol, longevity, SIRT1, gut microbiome, NAFLD, PCOS

Related Compounds

Browse all peptides in the Encyclopedia →